Publications

  1. Fansa S, Ghusn W, Tama E, Nicolalde B, Anazco D, D'Andre SD, Faubion SS, Shufelt CL, Acosta A, Hurtado MD. Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors. Breast Cancer Res Treat. 2024 Dec; 208 (3):553-563 Epub 2024 July 30
    View PubMed
  2. Anazco D, Espinosa MA, Cifuentes L, Kassmeyer B, Schmidt TM, Fansa S, Campos A, Tama E, Harmsen WS, Hurtado MD, Hensrud DD, Acosta A. Efficacy of in-person versus digital enhanced lifestyle interventions in adults with overweight and obesity. Obes Pillars. 2024 Dec; 12:100133 Epub 2024 Oct 16
    View PubMed
  3. Gala K, Ghusn W, Fansa S, Anazco D, Storm AC, Abu Dayyeh BK, Acosta A. Impact of Leptin-Melanocortin Pathway Genetic Variants on Weight Loss Outcomes After Endoscopic Transoral Outlet Reduction. Obes Surg. 2024 Nov; 34 (11):4203-4210 Epub 2024 Oct 17
    View PubMed
  4. Gala K, Ghusn W, Acosta A. Precision Medicine in Bariatric Procedures. Gastrointest Endosc Clin N Am. 2024 Oct; 34 (4):765-779 Epub 2024 Apr 16
    View PubMed
  5. Wang Y, Huang Y, Al Jawish MM, Bakheet NG, Acosta A, Ordog T, Clift K, Chase K, Kumbhari V, Badurdeen DS. Rising Obesity-Associated Mortality in Men: Exploration of Gender Disparity from the Global Burden of Disease Study, 1990-2019. J Gen Intern Med. 2024 Sep 20 Epub 2024 Sept 20
    View PubMed
  6. McRae AN, Ticho AL, Liu Y, Ricardo-Silgado ML, Mangena NN, Jassir FF, Gonzalez-Izundegui D, Calderon G, Rohakhtar FR, Simon V, Li Y, Leggett C, Hurtado D, LaRusso N, Acosta AJ. Regulator of G-protein signaling expression in human intestinal enteroendocrine cells and potential role in satiety hormone secretion in health and obesity. EBioMedicine. 2024 Sep; 107:105283 Epub 2024 Aug 13
    View PubMed
  7. Ghusn W, Calderon G, Abu Dayyeh BK, Acosta A. Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity. Clin Endosc. 2024 Aug 29 [Epub ahead of print]
    View PubMed
  8. Anazco D, Acosta A. Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy. Int J Obes (Lond). 2024 Aug 10 [Epub ahead of print]
    View PubMed
  9. Anazco D, Fansa S, Ghusn W, Gala K, Nicolalde B, Tama E, Calderon G, Bledsoe AC, Hurtado MD, Murray JA, Acosta A. Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study. J Clin Gastroenterol. 2024 Aug 1; 58 (7):650-655 Epub 2024 Aug 01
    View PubMed
  10. Anazco D, Fansa S, Hurtado MD, Camilleri M, Acosta A. Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist. Clin Gastroenterol Hepatol. 2024 Jun; 22 (6):1333-1335.e2 Epub 2023 Dec 02
    View PubMed
  11. Ghusn W, Cifuentes L, Anazco D, Fansa S, Tama E, Campos A, Gala K, Hurtado DM, Acosta A. Cumulative effect of obesity phenotypes on body weight and body mass index. Int J Obes (Lond). 2024 Jun; 48 (6):884-890 Epub 2024 Feb 28
    View PubMed
  12. Ghusn W, Fansa S, Anazco D, Tama E, Cifuentes L, Gala K, De La Rosa A, Sacoto D, Campos A, Feris F, Hurtado D, Acosta A. The association between previous use of anti-obesity medication and semaglutide weight loss outcomes. Diabetes Obes Metab. 2024 Jun; 26 (6):2167-2175 Epub 2024 Mar 12
    View PubMed
  13. Anazco D, Acosta A, Cathcart-Rake EJ, D'Andre SD, Hurtado MD. Weight-centric prevention of cancer. Obes Pillars. 2024 Jun; 10:100106 Epub 2024 Mar 05
    View PubMed
  14. Ghusn W, Anazco D, Fansa S, Tama E, Cifuentes L, Gala K, Calderon G, Collazo-Clavell ML, Hurtado MD, Acosta A. Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery score. EClinicalMedicine. 2024 Jun; 72:102625 Epub 2024 May 07
    View PubMed
  15. Acosta A, Cifuentes L, Anazco D, O'Connor T, Hurtado M, Ghusn W, Campos A, Fansa S, McRae A, Madhusudhan S, Kolkin E, Ryks M, Harmsen W, Abu Dayyeh B, Hensrud D, Camilleri M. Unraveling the Variability of Human Satiation: Implications for Precision Obesity Management. Res Sq. 2024 May 23
    View PubMed
  16. Cifuentes L, Ghusn W, Campos A, Bublitz JT, Hurtado MD, Olson J, Acosta A. Leptin-Melanocortin pathway variants and gastric emptying in patients with obesity. Neurogastroenterol Motil. 2024 May; 36 (5):e14764 Epub 2024 Feb 15
    View PubMed
  17. Ghusn W, Fansa S, Anazco D, Tama E, Nicolalde B, Gala K, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feres F, Hurtado MD, Acosta A. Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study. Int J Obes (Lond). 2024 May; 48 (5):662-667 Epub 2024 Feb 01
    View PubMed
  18. Fansa S, Acosta A. The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management. Diabetes Obes Metab. 2024 Apr; 26 Suppl 2:46-63 Epub 2024 Mar 19
    View PubMed
  19. Camilleri M, Acosta A. Newer pharmacological interventions directed at gut hormones for obesity. Br J Pharmacol. 2024 Apr; 181 (8):1153-1164 Epub 2023 Nov 30
    View PubMed
  20. Hage K, Ma P, Ghusn W, Ikemiya K, Acosta A, Vierkant RA, Abu Dayyeh BK, Higa KD, Ghanem OM. A Matched Comparative Analysis of Type-2 Diabetes Mellitus Remission Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Surg Innov. 2024 Apr; 31 (2):148-156 Epub 2024 Jan 22
    View PubMed
  21. Hurtado MD, Tama E, Fansa S, Ghusn W, Anazco D, Acosta A, Faubion SS, Shufelt CL. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause. 2024 Apr 1; 31 (4):266-274 Epub 2024 Mar 05
    View PubMed
  22. Ghusn W, Hage K, Vierkant RA, Collazo-Clavell ML, Abu Dayyeh BK, Kellogg TA, Acosta A, Ghanem OM. Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores. Diabetes Res Clin Pract. 2024 Feb; 208:111091 Epub 2024 Jan 13
    View PubMed
  23. Campos A, Marek T, Calderon G, Ghusn W, Cifuentes L, Sim LA, Camilleri M, Dayyeh BA, Port JD, Acosta A. Neurohormonal response patterns to hunger, satiation, and postprandial fullness in normal weight, anorexia nervosa, and obesity. Neurogastroenterol Motil. 2024 Jan; 36 (1):e14695 Epub 2023 Nov 05
    View PubMed
  24. Gala K, Ghusn W, Brunaldi V, Vargas EJ, Storm AC, Acosta A, Dayyeh BKA. Applicability of individualized metabolic surgery score for prediction of diabetes remission after endoscopic sleeve gastroplasty. Ther Adv Gastrointest Endosc. 2024 Jan-Dec; 17:26317745241247175 Epub 2024 Apr 25
    View PubMed
  25. Busebee B, Ghusn W, Cifuentes L, Acosta A. Obesity: A Review of Pathophysiology and Classification. Mayo Clin Proc. 2023 Dec; 98 (12):1842-1857 Epub 2023 Oct 11
    View PubMed
  26. Anazco D, Ghusn W, Campos A, Cifuentes L, Fansa S, Tama E, Bublitz JT, Gala K, Hurtado MD, Olson JE, Acosta A. Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study. Obes Surg. 2023 Nov; 33(11):3502-3509. Epub 2023 Oct 06.
    View PubMed
  27. Pham JT, Ghusn W, Acosta A, Loftus EV Jr, Johnson AM. Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease. Am J Gastroenterol. 2023 Oct 9 Epub 2023 Oct 09
    View PubMed
  28. Ghusn W, Ma P, Ikemiya K, Hage K, Abboud DM, Vierkant RA, Kendrick ML, Higa K, Acosta A, Ghanem OM. The role of diabetes severity scores in predicting disease remission in patients with BMI > 50 kg/m(2) undergoing Roux-En-Y gastric bypass and sleeve gastrectomy: a multi-centered study. Surg Endosc. 2023 Sep; 37 (9):7114-7120 Epub 2023 June 13
    View PubMed
  29. Ghusn W, Acosta A, Kane S. An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy. Gastroenterology. 2023 Jul; 165 (1):40-43 Epub 2022 Dec 31
    View PubMed
  30. Ghusn W, Ikemiya K, Al Annan K, Acosta A, Dayyeh BKA, Lee E, Spaniolas K, Kendrick M, Higa K, Ma P, Ghanem OM. Diabetes Mellitus Remission in Patients with BMI > 50 kg/m(2) after Bariatric Surgeries: A Real-World Multi-Centered Study. Obes Surg. 2023 Jun; 33 (6):1838-1845 Epub 2023 Apr 28
    View PubMed
  31. Vargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, Acosta A, Lake D, Fidler J, Bharucha AE, Camilleri M, Abu Dayyeh BK. Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study. Gut. 2023 Jun; 72 (6):1073-1080 Epub 2022 Oct 14
    View PubMed
  32. Cifuentes L, Ghusn W, Feris F, Campos A, Sacoto D, De la Rosa A, McRae A, Rieck T, Mansfield S, Ewoldt J, Friend J, Grothe K, Lennon RJ, Hurtado MD, Clark MM, Camilleri M, Hensrud DD, Acosta A. Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study. EClinicalMedicine. 2023 Apr; 58:101923 Epub 2023 Mar 24
    View PubMed
  33. Gala K, Ghusn W, Fansa S, Abu Dayyeh BK, Ghanem OM, Kellogg T, Acosta A. Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Transoral Outlet Reduction After Roux-en-Y Gastric Bypass: A Case-Control Study and Review of Literature. Obes Surg. 2023 Apr; 33 (4):1284-1288 Epub 2023 Jan 28
    View PubMed
  34. Cifuentes L, Campos A, Sacoto D, Ghusn W, De la Rosa A, Feris F, McRae A, Bublitz JT, Hurtado MD, Olson J, Acosta A. Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants. Mayo Clin Proc. 2023 Apr; 98 (4):533-540 Epub 2022 Dec 20
    View PubMed
  35. Nakanishi H, Teixeira AF, Matar RH, Hage K, Acosta AJ, Abu Dayyeh BK, Pullatt R, Clapp B, Ghanem OM. Impact on Mid-Term Health-Related Quality of Life after Duodenal Switch: a Systematic Review and Meta-Analysis. Obes Surg. 2023 Mar; 33(3):769-779. Epub 2023 Jan 07.
    View PubMed
  36. Sannaa W, Dilmaghani S, BouSaba J, Maselli D, Atieh J, Eckert D, Taylor AL, Harmsen WS, Acosta A, Camilleri M. Factors associated with successful weight loss after liraglutide treatment for obesity. Diabetes Obes Metab. 2023 Feb; 25 (2):377-386 Epub 2022 Oct 24
    View PubMed
  37. Maroun J, Vahibe A, Shah M, Mundi MS, Acosta A, McKenzie TJ, Kellogg TA, Ghanem OM. Impact of Chronic Immunosuppression on Short-, Mid-, and Long-Term Bariatric Surgery Outcomes. Obes Surg. 2023 Jan; 33 (1):240-246 Epub 2022 Dec 05
    View PubMed
  38. Ghusn W, Acosta A, Kane S. An unusual etiology of bleeding in an inflammatory bowel disease surveillance colonoscopy. Gastroenterology. 2023; 165 (1):40-3
  39. Ebner DW, Burger KN, Broderick B, Mahoney DW, Kellogg TA, Acosta A, Kisiel JB. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery. Gastro Hep Adv. 2023; 2 (7):902-910 Epub 2023 July 01
    View PubMed
  40. Feris F, McRae A, Kellogg TA, McKenzie T, Ghanem O, Acosta A. Mucosal and hormonal adaptations after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2023 Jan; 19 (1):37-49 Epub 2022 Sept 13
    View PubMed
  41. Ghusn W, Cifuentes L, Campos A, Sacoto D, De La Rosa A, Feris F, Calderon G, Gonzalez-Izundegui D, Stutzman J, Hurtado MD, Camilleri M, Acosta A. Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity. Gastro Hep Adv. 2023; 2 (1):121-128 Epub 2022 Aug 07
    View PubMed
  42. De la Rosa A, Ghusn W, Sacoto D, Campos A, Cifuentes L, Feris F, Busebee B, Calderon G, Acosta A, Hurtado MD. A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center. Obes Pillars. 2022 Dec; 4:100046 Epub 2022 Dec 01
    View PubMed
  43. Ghusn W, Hurtado MD, Acosta A. Weight-centric treatment of type 2 diabetes mellitus. Obes Pillars. 2022 Dec; 4:100045 Epub 2022 Nov 24
    View PubMed
  44. Hurtado MD, Cifuentes L, Campos A, De La Rosa A, Kapoor E, Faubion SS, Hensrud DD, Camilleri M, Acosta A. Sex as an independent variable in the measurement of satiation: a retrospective cohort study. Int J Obes (Lond). 2022 Dec; 46 (12):2156-2162 Epub 2022 Oct 13
    View PubMed
  45. Hashem AM, Cifuentes L, Calderon G, Ricardo-Silgado ML, Gonzalez-Izundegui D, Campos A, McRae A, Franks S, Hurtado MD, Burton D, Petterson XM, Lanza IR, Camilleri M, Acosta A. Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity. Am J Physiol Gastrointest Liver Physiol. 2022 Sep 1; 323 (3):G157-G164 Epub 2022 June 21
    View PubMed
  46. Cifuentes L, Campos A, Silgado MLR, Kelpin S, Stutzman J, Hurtado MD, Grothe K, Hensrud DD, Clark MM, Acosta A. Association between anxiety and eating behaviors in patients with obesity. Obes Pillars. 2022 Sep; 3:100021 Epub 2022 May 17
    View PubMed
  47. Ghusn W, Bouchard C, Frye MA, Acosta A. Weight-centric treatment of depression and chronic pain. Obes Pillars. 2022 Sep; 3:100025 Epub 2022 June 23
    View PubMed
  48. Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Netw Open. 2022 Sep 1; 5 (9):e2231982 Epub 2022 Sept 01
    View PubMed
  49. Maselli D, Atieh J, Clark MM, Eckert D, Taylor A, Carlson P, Burton DD, Busciglio I, Harmsen WS, Vella A, Acosta A, Camilleri M. Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial. Obesity (Silver Spring). 2022 Aug; 30 (8):1608-1620
    View PubMed
  50. Campos A, Cifuentes L, Hashem A, Busebee B, Hurtado-Andrade MD, Ricardo-Silgado ML, McRae A, De la Rosa A, Feris F, Bublitz JT, Hensrud D, Camilleri M, Kellogg TA, Eckel-Passow JE, Olson J, Acosta A. Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study. Obes Surg. 2022 Aug; 32 (8):2632-2640 Epub 2022 June 03
    View PubMed
  51. Ricardo-Silgado ML, Singh S, Cifuentes L, Decker PA, Gonzalez-Izundegui D, Moyer AM, Hurtado MD, Camilleri M, Bielinski SJ, Acosta A. Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC Med. 2022 Jul 26; 20 (1):261 Epub 2022 July 26
    View PubMed
  52. Rapaka B, Maselli DB, Lopez-Nava G, Bautista-Castano I, Matar R, Jaruvongvanich V, Vargas EJ, Storm AC, Acosta A, Abu Dayyeh BK. Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty: results of a prospective study. Chin Med J (Engl). 2022 May 20; 135 (10):1234-1241
    View PubMed
  53. Cifuentes L, Hurtado MD, Cortes TM, Gonzales K, Acosta A, Shah M, Collazo-Clavell ML. Evaluation and Management of Patients Referred for Post-Bariatric Surgery Hypoglycemia at a Tertiary Care Center. Obes Surg. 2022 May; 32 (5):1578-1585 Epub 2022 Mar 09
    View PubMed
  54. Campos A, Port JD, Acosta A. Integrative Hedonic and Homeostatic Food Intake Regulation by the Central Nervous System: Insights from Neuroimaging. Brain Sci. 2022 Mar 24; 12 (4)
    View PubMed
  55. Calderon G, Gonzalez-Izundegui D, Shan KL, Garcia-Valencia OA, Cifuentes L, Campos A, Collazo-Clavell ML, Shah M, Hurley DL, Abu Lebdeh HS, Sharma M, Schmitz K, Clark MM, Grothe K, Mundi MS, Camilleri M, Abu Dayyeh BK, Hurtado Andrade MD, Mokadem MA, Acosta A. Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience. Int J Obes (Lond). 2022 Mar; 46 (3):555-563 Epub 2021 Nov 22
    View PubMed
  56. Cifuentes L, Acosta A. Homeostatic regulation of food intake. Clin Res Hepatol Gastroenterol. 2022 Feb; 46 (2):101794 Epub 2021 Sept 01
    View PubMed
  57. Sacoto D, Hurtado MD, Acosta A. Precision Medicine and Obesity. Handb Exp Pharmacol. 2022; 274:467-485
    View PubMed
  58. McRae A, Ricardo-Silgado ML, Liu Y, Calderon G, Gonzalez-Izundegui D, Rohakhtar FR, Simon V, Li Y, Acosta A. A Protocol for the Cryopreservation of Human Intestinal Mucosal Biopsies Compatible With Single-Cell Transcriptomics and Ex Vivo Studies. Front Physiol. 2022; 13:878389 Epub 2022 May 05
    View PubMed
  59. Abu Dayyeh BK, Maselli DB, Rapaka B, Lavin T, Noar M, Hussan H, Chapman CG, Popov V, Jirapinyo P, Acosta A, Vargas EJ, Storm AC, Bazerbachi F, Ryou M, French M, Noria S, Molina D, Thompson CC. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet. 2021 Nov 27; 398 (10315):1965-1973 Epub 2021 Nov 15
    View PubMed
  60. Hashem A, Khalouf A, Acosta A. Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. Semin Liver Dis. 2021 Nov; 41 (4):435-447 Epub 2021 July 09
    View PubMed
  61. Gonzalez-Izundegui D, Campos A, Calderon G, Ricardo-Silgado ML, Cifuentes L, Decker PA, Vargas EJ, Tran L, Burton D, Abu Dayyeh B, Camilleri M, Eckel-Passow JE, Acosta A. Association of gastric emptying with postprandial appetite and satiety sensations in obesity. Obesity (Silver Spring). 2021 Sep; 29(9):1497-1507. Epub 2021 Jul 27.
    View PubMed
  62. Cifuentes L, Hurtado A MD, Eckel-Passow J, Acosta A. Precision Medicine for Obesity. Dig Dis Interv. 2021 Sep; 5 (3):239-248
    View PubMed
  63. Hawa F, Vargas EJ, Acosta A, McRae A, Bazerbachi F, Abu Dayyeh BK. Contamination of single fluid-filled intragastric balloons with orogastric fluid is not associated with hyperinflation: an ex-vivo study and systematic review of literature. BMC Gastroenterol. 2021 Jul 12; 21 (1):286 Epub 2021 July 12
    View PubMed
  64. Ricardo-Silgado ML, McRae A, Acosta A. Role of Enteroendocrine Hormones in Appetite and Glycemia. Obes Med. 2021 May; 23 Epub 2021 Mar 12
    View PubMed
  65. Cifuentes L, Camilleri M, Acosta A. Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity-Therapeutic Implications. Nutrients. 2021 Apr 1; 13 (4) Epub 2021 Apr 01
    View PubMed
  66. Acosta A, Camilleri M, Abu Dayyeh B, Calderon G, Gonzalez D, McRae A, Rossini W, Singh S, Burton D, Clark MM. Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic. Obesity (Silver Spring). 2021 Apr; 29(4):662-671.
    View PubMed
  67. Hurtado A MD, Acosta A. Precision Medicine and Obesity. Gastroenterol Clin North Am. 2021 Mar; 50 (1):127-139 Epub 2021 Jan 05
    View PubMed
  68. Singh S, Ricardo-Silgado ML, Bielinski SJ, Acosta A. Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications. Obesity (Silver Spring). 2021 Feb; 29 (2):265-273
    View PubMed
  69. Bazerbachi F, Vargas EJ, Rizk M, Maselli DB, Mounajjed T, Venkatesh SK, Watt KD, Port JD, Basu R, Acosta A, Hanouneh I, Gara N, Shah M, Mundi M, Clark M, Grothe K, Storm AC, Levy MJ, Abu Dayyeh BK. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2021 Jan; 19 (1):146-154.e4 Epub 2020 Apr 30
    View PubMed
  70. Pajot G, Camilleri M, Calderon G, Davis J, Eckert D, Burton D, Acosta A. Association between gastrointestinal phenotypes and weight gain in younger adults: a prospective 4-year cohort study. Int J Obes (Lond). 2020 Dec; 44 (12):2472-2478 Epub 2020 May 15
    View PubMed
  71. Davis J, Camilleri M, Eckert D, Burton D, Joyner M, Acosta A. Physical activity is associated with accelerated gastric emptying and increased ghrelin in obesity. Neurogastroenterol Motil. 2020 Nov; 32 (11):e13879 Epub 2020 May 11
    View PubMed
  72. Lopez-Nava G, Jaruvongvanich V, Storm AC, Maselli DB, Bautista-Castano I, Vargas EJ, Matar R, Acosta A, Abu Dayyeh BK. Personalization of Endoscopic Bariatric and Metabolic Therapies Based on Physiology: a Prospective Feasibility Study with a Single Fluid-Filled Intragastric Balloon. Obes Surg. 2020 Sep; 30 (9):3347-3353
    View PubMed
  73. Vijayvargiya P, Chedid V, Wang XJ, Atieh J, Maselli D, Burton DD, Clark MM, Acosta A, Camilleri M. Associations of gastric volumes, ingestive behavior, calorie and volume intake, and fullness in obesity. Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1; 319 (2):G238-G244 Epub 2020 July 06
    View PubMed
  74. Calderon G, McRae A, Rievaj J, Davis J, Zandvakili I, Linker-Nord S, Burton D, Roberts G, Reimann F, Gedulin B, Vella A, LaRusso NF, Camilleri M, Gribble FM, Acosta A. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine. 2020 May; 55:102759 Epub 2020 Apr 25
    View PubMed
  75. Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D, Vella A, Acosta A, Camilleri M. GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. J Clin Endocrinol Metab. 2020 May 1; 105 (5)
    View PubMed
  76. Vargas EJ, Bazerbachi F, Calderon G, Prokop LJ, Gomez V, Murad MH, Acosta A, Camilleri M, Abu Dayyeh BK. Changes in Time of Gastric Emptying After Surgical and Endoscopic Bariatrics and Weight Loss: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 Jan; 18 (1):57-68.e5 Epub 2019 Apr 04
    View PubMed
  77. Vargas EJ, Bazerbachi F, Storm AC, Rizk M, Acosta A, Grothe K, Clark MM, Mundi MS, Pesta CM, Bali A, Ibegbu E, Moore RL, Kumbhari V, Curry T, Sharaiha RZ, Abu Dayyeh BK. Effectiveness of Online Aftercare Programs Following Intragastric Balloon Placement for Obesity Is Similar to Traditional Follow-up: a Large Propensity Matched US Multicenter Study. Obes Surg. 2019 Dec; 29 (12):4036-4042
    View PubMed
  78. Camilleri M, Wieben E, Eckert D, Carlson P, Hurley O'Dwyer R, Gibbons D, Acosta A, Klee EW. Familial chronic megacolon presenting in childhood or adulthood: Seeking the presumed gene association. Neurogastroenterol Motil. 2019 Apr; 31 (4):e13550 Epub 2019 Jan 20
    View PubMed
  79. Camilleri M, Acosta A. Combination Therapies for Obesity. Metab Syndr Relat Disord. 2018 Oct; 16 (8):390-394 Epub 2018 July 11
    View PubMed
  80. Chedid V, Vijayvargiya P, Carlson P, Van Malderen K, Acosta A, Acosta A, Zinsmeister A, Camilleri M. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study. Neurogastroenterol Motil. 2018 Jul; 30 (7):e13313 Epub 2018 Feb 28
    View PubMed
  81. Vargas EJ, Pesta CM, Bali A, Ibegbu E, Bazerbachi F, Moore RL, Kumbhari V, Sharaiha RZ, Curry TW, DosSantos G, Schmitz R, Agnihotri A, Novikov AA, Pitt T, Dunlap MK, Herr A, Aronne L, Ledonne E, Kadouh HC, Cheskin LJ, Mundi MS, Acosta A, Gostout CJ, Abu Dayyeh BK. Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clin Gastroenterol Hepatol. 2018 Jul; 16 (7):1073-1080.e1 Epub 2018 Feb 07
    View PubMed
  82. Halawi H, Vijayvargiya P, Busciglio I, Oduyebo I, Khemani D, Ryks M, Rhoten D, Burton D, Szarka LA, Acosta A, Acosta A, Camilleri M. Effects of naloxegol on whole gut transit in opioid-naive healthy subjects receiving codeine: A randomized, controlled trial. Neurogastroenterol Motil. 2018 May; 30 (5):e13298 Epub 2018 Feb 06
    View PubMed
  83. Vargas EJ, Bazerbachi F, Rizk M, Rustagi T, Acosta A, Wilson EB, Wilson T, Neto MG, Zundel N, Mundi MS, Collazo-Clavell ML, Meera S, Abu-Lebdeh HS, Lorentz PA, Grothe KB, Clark MM, Kellogg TA, McKenzie TJ, Kendrick ML, Topazian MD, Gostout CJ, Abu Dayyeh BK. Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc. 2018 Jan; 32 (1):252-259 Epub 2017 June 29
    View PubMed
  84. Pajot G, Calderon G, Acosta A. Endoscopic Treatments for Obesity. Curr Treat Options Gastroenterol. 2017 Dec; 15 (4):660-675
    View PubMed
  85. Halawi H, Khemani D, Eckert D, O'Neill J, Kadouh H, Grothe K, Clark MM, Burton DD, Vella A, Acosta A, Zinsmeister AR, Camilleri M. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017 Dec; 2 (12):890-899 Epub 2017 Sept 27
    View PubMed
  86. Park SY, Acosta A, Camilleri M, Burton D, Harmsen WS, Fox J, Szarka LA. Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms. Am J Gastroenterol. 2017 Nov; 112 (11):1689-1699 Epub 2017 Sept 12
    View PubMed
  87. Halawi H, Camilleri M, Acosta A, Vazquez-Roque M, Oduyebo I, Burton D, Busciglio I, Zinsmeister AR. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health. Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1; 313 (5):G442-G447 Epub 2017 Aug 03
    View PubMed
  88. Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017 Oct; 27 (10):2649-2655
    View PubMed
  89. Nelson AD, Camilleri M, Acosta A, Boldingh A, Busciglio I, Burton D, Ryks M, Zinsmeister AR. A single-center, prospective, double-blind, sham-controlled, randomized study of the effect of a vibrating capsule on colonic transit in patients with chronic constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Feb 08
    View PubMed
  90. Park SY, Khemani D, Acosta A, Eckert D, Camilleri M. Rectal gas volume: Defining cut-offs for screening for evacuation disorders in patients with constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Mar 06
    View PubMed
  91. Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May; 152 (7):1656-1670 Epub 2017 Feb 10
    View PubMed
  92. Khemani D, Camilleri M, Roldan A, Nelson AD, Park SY, Acosta A, Zinsmeister AR. Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses. Neurogastroenterol Motil. 2017 May; 29 (5) Epub 2016 Dec 25
    View PubMed
  93. Acosta A, Streett S, Kroh MD, Cheskin LJ, Saunders KH, Kurian M, Schofield M, Barlow SE, Aronne L. White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. Clin Gastroenterol Hepatol. 2017 May; 15 (5):631-649.e10 Epub 2017 Feb 27
    View PubMed
  94. Valentin N, Camilleri M, Carlson P, Harrington SC, Eckert D, O'Neill J, Burton D, Chen J, Shaw AL, Acosta A. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep. 2017 Mar; 5 (5)
    View PubMed
  95. Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol. 2017 Jan; 15 (1):37-43.e1 Epub 2015 Dec 31
    View PubMed
  96. Kadouh HC, Acosta A. Current paradigms in the etiology of obesity Techniques In Gastrointestinal Endoscopy. 2017 Jan; 19 (1):2-11
  97. Acosta A, Camilleri M. A working paradigm for the treatment of obesity in gastrointestinal practice. Tech Gastrointest Endosc. 2017 Jan; 19 (1):52-60 Epub 2017 Jan 25
    View PubMed
  98. Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016 Dec; 65 (12):1951-1959 Epub 2015 Sept 07
    View PubMed
  99. Iturrino J, Camilleri M, Acosta A, O'Neill J, Burton D, Edakkanambeth Varayil J, Carlson PJ, Zinsmeister AR, Hurt R. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 2016 Nov; 40 (8):1089-1095 Epub 2015 July 28
    View PubMed
  100. Nelson AD, Camilleri M, Acosta A, Busciglio I, Linker Nord S, Boldingh A, Rhoten D, Ryks M, Burton D. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers. Neurogastroenterol Motil. 2016 Nov; 28 (11):1705-1713 Epub 2016 June 09
    View PubMed
  101. Camilleri M, Carlson P, Valentin N, Acosta A, O'Neill J, Eckert D, Dyer R, Na J, Klee EW, Murray JA. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1; 311 (3):G365-76 Epub 2016 July 21
    View PubMed
  102. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Carlson P, Vella A, Zinsmeister AT. Association of obesity-related genes with quantitative gastrointestinal traits in obesity Genes and Nutrition.2016;().
  103. Mouchli MA, Camilleri M, Lee T, Parthasarathy G, Vijayvargiya P, Halland M, Acosta A, Bharucha AE. Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation. Neurogastroenterol Motil. 2016 Jun; 28 (6):871-8 Epub 2016 Feb 03
    View PubMed
  104. Acosta A, Camilleri M, Shin A, Linker Nord S, O'Neill J, Gray AV, Lueke AJ, Donato LJ, Burton DD, Szarka LA, Zinsmeister AR, Golden PL, Fodor A. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2016 May 26; 7:e173
    View PubMed
  105. Acosta A, Camilleri M, Busciglio I, Boldingh A, Nelson AD, Burton D. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci. 2016 Mar; 61 (3):852-60 Epub 2015 Oct 14
    View PubMed
  106. Acosta A, Camilleri M, Linker-Nord S, Busciglio I, Iturrino J, Szarka LA, Zinsmeister AR. A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016 Jan 31; 22 (1):69-77
    View PubMed
  107. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister A. Associations of variations of 5-HT2c receptor genes with satiation in overweight and obese adults Appetite. 2016; 83(1):48-56.
    View PubMed
  108. Camilleri M, Acosta A. Gastrointestinal traits: individualizing therapy for obesity with drugs and devices. Gastrointest Endosc. 2016 Jan; 83 (1):48-56 Epub 2015 Aug 10
    View PubMed
  109. Acosta A, Camilleri M, Kolar G, Iturrino J, Szarka LA, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR, Spence SC, Gottesdiener K, Bouras EP, Vazquez-Roque MI. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial. Clin Gastroenterol Hepatol. 2015 Dec; 13: (13)2312-9.e1.
    View PubMed
  110. Acosta A, Camilleri M, Burton D, O'Neill J, Eckert D, Carlson P, Zinsmeister AR. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep. 2015 Nov; 3 (11)
    View PubMed
  111. Nelson AD, Mouchli MA, Valentin N, Deyle D, Pichurin P, Acosta A, Camilleri M. Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic. Neurogastroenterol Motil. 2015 Nov; 27 (11):1657-66 Epub 2015 Sept 16
    View PubMed
  112. O'Dwyer RH, Acosta A, Camilleri M, Burton D, Busciglio I, Bharucha AE. Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults. Dig Dis Sci. 2015 Aug; 60 (8):2398-407 Epub 2015 Apr 14
    View PubMed
  113. Camilleri M, Carlson P, Acosta A, Busciglio I. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1; 309 (1):G10-20 Epub 2015 Apr 30
    View PubMed
  114. Ryan D, Acosta A. GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond. Obesity (Silver Spring). 2015 Jun; 23 (6):1119-29 Epub 2015 May 09
    View PubMed
  115. Valentin N, Acosta A, Camilleri M. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials. Expert Opin Investig Drugs. 2015 Jun; 24 (6):769-79
    View PubMed
  116. Shin A, Acosta A, Camilleri M, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Clin Gastroenterol Hepatol. 2015 Apr; 13: (4)701-8.e1.
    View PubMed
  117. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Lanza IR, Nair KS, Burton D, O'Neill J, Eckert D, Carlson P, Vella A, Zinsmeister AR. Association of UCP-3 rs1626521 with obesity and stomach functions in humans. Obesity (Silver Spring). 2015 Apr; 23 (4):898-906 Epub 2015 Mar 07
    View PubMed
  118. Camilleri M, Acosta A. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015 Mar; 27 (3):324-32 Epub 2014 Dec 29
    View PubMed
  119. Acosta A, Camilleri M. Prokinetics in gastroparesis. Gastroenterol Clin North Am. 2015 Mar; 44 (1):97-111 Epub 2014 Dec 23
    View PubMed
  120. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology. 2015 Mar; 148 (3):537-546.e4 Epub 2014 Dec 06
    View PubMed
  121. Camilleri M, Acosta A, Busciglio I, Boldingh A, Dyer RB, Zinsmeister AR, Lueke A, Gray A, Donato LJ. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2015 Mar; 41 (5):438-48 Epub 2015 Jan 16
    View PubMed
  122. Acosta A, Camilleri M. Invited editorial: Pharmacogenetics in irritable bowel syndrome Exp Opin Drug Metab Toxicol.2015;().
  123. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil. 2014 Dec; 26 (12):1677-85 Epub 2014 Sept 22
    View PubMed
  124. Acosta A, Azzalin A, Emmons CJ, Shuster JJ, Jay M, Lo MC. Improving residents' clinical approach to obesity: impact of a multidisciplinary didactic curriculum. Postgrad Med J. 2014 Nov; 90: (1069)630-7.
    View PubMed
  125. Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014 Oct; 109 (10):1621-30 Epub 2014 July 29
    View PubMed
  126. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1; 307 (5):G508-16 Epub 2014 July 10
    View PubMed
  127. Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014 Jul; 7 (4):167-75
    View PubMed
  128. Camilleri M, Carlson P, Acosta A, Busciglio I, Nair AA, Gibbons SJ, Farrugia G, Klee EW. RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15; 306 (12):G1089-98 Epub 2014 Apr 24
    View PubMed
  129. Acosta A, Camilleri M. Gastrointestinal morbidity in obesity. Ann N Y Acad Sci. 2014 Apr; 1311:42-56 Epub 2014 Mar 06
    View PubMed
  130. Acosta A, Abu Dayyeh BK, Port JD, Camilleri M. Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut. 2014 Apr; 63 (4):687-95 Epub 2014 Jan 08
    View PubMed
  131. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults. Genes Nutr. 2014 Mar; 9 (2):384 Epub 2014 Jan 24
    View PubMed
  132. Bick BL, Acosta Cardenas AJ, Vege SS. 52-year-old man with acute midabdominal pain. Mayo Clin Proc. 2014 Jan; 89: (1)115-9.
    View PubMed
  133. Hurtado MD, Sergeyev VG, Acosta A, Spegele M, La Sala M, Waler NJ, Chiriboga-Hurtado J, Currlin SW, Herzog H, Dotson CD, Gorbatyuk OS, Zolotukhin S. Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion. J Neurosci. 2013 Nov 20; 33: (47)18368-80.
    View PubMed
  134. Anton SD, Heekin K, Simkins C, Acosta A. Differential effects of adulterated versus unadulterated forms of linoleic acid on cardiovascular health. J Integr Med. 2013 Jan; 11: (1)2-10.
    View PubMed
  135. Polyak S, Mach A, Porvasnik S, Dixon L, Conlon T, Erger KE, Acosta A, Wright AJ, Campbell-Thompson M, Zolotukhin I, Wasserfall C, Mah C. Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1; 302: (3)G296-308.
    View PubMed
  136. Hurtado MD, Acosta A, Riveros PP, Baum BJ, Ukhanov K, Brown AR, Dotson CD, Herzog H, Zolotukhin S. Distribution of Y-receptors in murine lingual epithelia. PLoS One. 2012; 7: (9)e46358.
    View PubMed
  137. Acosta A, Hurtado MD, Gorbatyuk O, La Sala M, Duncan D, Aslanidi G, Campbell-Thompson M, Zhang L, Herzog H, Voutetakis A, Baum BJ, Zolotukhin S. Salivary PYY: a putative bypass to satiety. PLoS One. 2011; 6: (10)e26137.
    View PubMed
  138. Paz-y-Mino C, Fiallo BF, Morillo SA, Acosta A, Gimenez P, Ocampo L, Leone PE. Analysis of the polymorphism [gIVS12-6T > C] in the hMSH2 gene in lymphoma and leukemia. Leuk Lymphoma. 2003 Mar; 44: (3)505-8.
    View PubMed